AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1299733
Drug: Peri-operative antibiotics
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peri-operative antibiotics for clean-contaminated (class B) and contaminated (class C) cases only.
Trial: 1299733
Drug: Routine group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine group received prolonged antibiotics.
Trial: 1299733
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics for clean cases (class A).
Trial: 6380856
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg orally 4 times a day during hospitalization + Metoprolol 15 mg intravenously 20 min after initial administration, then 50 mg 4 times a day
Trial: 6380856
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Metoprolol 15 mg intravenously 20 min after initial administration, then 50 mg 4 times a day
Trial: 28921723
Drug: Prophylactic cefalexin
RxNorm normalized name: cefalexin
DrugBank: Cephalexin (DB00567)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prophylactic cefalexin (22 mg/kg twice daily)
Trial: 24716713
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) at 4 Joules
Trial: 24716713
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) at 6 Joules
Trial: 24716713
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) at 8 Joules
Trial: 24716713
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) protocol that achieved the best muscle performance in phase 1
Trial: 18400585
Drug: Cetrorelix 0.25
RxNorm normalized name: cetrorelix 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix 0.25 mg
Trial: 18400585
Drug: Cetrorelix 0.2
RxNorm normalized name: cetrorelix 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix 0.2 mg
Trial: 18400585
Drug: Cetrorelix 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetrorelix 0.15 mg
Trial: 18400585
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (LA) 0.5 mg/day
Trial: 18400585
Drug: Single half-dose
RxNorm normalized name: propranolol hydrochloride Extended Release Oral Capsule [Half-Betadur CR]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single half-dose LA depot 1.88 mg
Trial: 12795797
Drug: 0.5% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% chlorhexidine gel
Trial: 10599334
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 mg per day
Trial: 10599334
Drug: Thalidomide 300
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide 300 mg per day
Trial: 6857583
Drug: Indomethacin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (50 mg four times per day for three days)
Trial: 6857583
Drug: Salbutamol treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol treatment
Trial: 29147795
Drug: Pregabalin 2
RxNorm normalized name: pregabalin 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin 2 mg/kg twice daily
Trial: 27401508
Drug: Prophylactic fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prophylactic fentanyl pectin nasal spray (FPNS) 15%-25% of total daily opioid dose
Trial: 26121347
Drug: Esomeprazole 5
RxNorm normalized name: esomeprazole 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 5 or 10 mg daily (< 20 kg) or 10 or 20 mg daily (≥ 20 kg) for 8 weeks
Trial: 12790216
Drug: Morphine 0.4
RxNorm normalized name: morphine 0.4 mg/mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.4 mg mL(‐1)
Trial: 12790216
Drug: Morphine 0.4
RxNorm normalized name: morphine 0.4 mg/mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.4 mg mL(‐1) + MgSO4 30 mg mL(‐1)
Trial: 12790216
Drug: Morphine 0.4
RxNorm normalized name: morphine 0.4 mg/mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 0.4 mg mL(‐1) + ketamine 1 mg mL(‐1)
Trial: 2062330
Drug: Plasma infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma infusion
Trial: 6192139
Drug: High dosage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dosage regimen (group A) - MMI: 60 +/- 14.5 mg/day or PTU: 693 +/- 173 mg/day, with T3 addition.
Trial: 6192139
Drug: Low dosage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dosage regimen (group B) - MMI: 13.6 +/- 7 mg/day or PTU: 180 +/- 58 mg/day, without T3 addition.
Trial: 24075228
Drug: Cultured allogeneic
RxNorm normalized name: allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen Medicated Patch [Stratagraft]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cultured allogeneic fibroblasts in a crystalloid suspension solution with 2% albumin
Trial: 24075228
Drug: Suspension solution
RxNorm normalized name: Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension solution alone
Trial: 24075228
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (fibroblasts and suspension solution)
Trial: 2971565
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bronchodilators
Trial: 23403474
Drug: Oral citicoline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral citicoline 500 mg twice a day
Trial: 22122817
Drug: Candesartan 32
RxNorm normalized name: candesartan 32 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 32 mg and HCT 25 mg
Trial: 22122817
Drug: HCT 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCT 25 mg
Trial: 19593887
Drug: Intraarticular +
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular + subacromial injection
Trial: 19593887
Drug: Intraarticular injection
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular injection
Trial: 17047178
Drug: Nutrison Pack
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrison Pack (1-L enteral feeding system)
Trial: 17047178
Drug: Glass bottle
RxNorm normalized name: bottlebrush pollen extract
DrugBank: Callistemon citrinus pollen (DB10943)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glass bottle system (0.5-L)
Trial: 12923727
Drug: Angiotensin antagonists,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin antagonists, lifestyle changes, and appropriate drugs to reduce cardiovascular risk factors
Trial: 12923727
Drug: Immunosuppressive therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunosuppressive therapies (corticosteroids, cyclosporine, mycophenolate, cyclophosphamide)
Trial: 10839912
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of epidural morphine and intravenous ketamine
Trial: 3730737
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific therapy (control)
Trial: 30866027
Drug: Nutritional counseling
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional counseling and medical therapy (treated)
Trial: 29678193
Drug: Prolonged grief-specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged grief-specific integrative cognitive behavioral therapy (PG-CBT)
Trial: 24956865
Drug: Pingshen decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pingshen decoction 1 dose/d, bid po for 8 weeks
Trial: 24956865
Drug: NephritisShu tablet,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NephritisShu tablet, 6 tablets, tid po for 8 weeks
Trial: 23356030
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose rifampicin (SDR) chemoprophylaxis
Trial: 19011427
Drug: Olanzapine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (20 mg/d)
Trial: 19011427
Drug: Aripiprazole (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (15 mg/d, increasing to 30 mg/d as needed)
Trial: 19011427
Drug: Control (Lorazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Lorazepam as needed, total dose ≤ 4 mg/d)
Trial: 16151977
Drug: Insulin glulisine
RxNorm normalized name: Insulin Glulisine
DrugBank: Insulin glulisine (DB01309)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Insulin glulisine (0.3 U/kg)
Trial: 16151977
Drug: Insulin lispro
RxNorm normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin lispro (0.3 U/kg)
Trial: 16151977
Drug: Regular human
RxNorm normalized name: insulin regular human recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular human insulin (0.3 U/kg)
Trial: 10999651
Drug: Salbutamol 8
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol 8 mg [β‐2]
Trial: 10999651
Drug: Pindolol 10
RxNorm normalized name: pindolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 10 mg [mainly β‐2]
Trial: 10999651
Drug: Xamoterol 200
RxNorm normalized name: xamoterol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol 200 mg [β‐1]
Trial: 8136625
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (1 unit/ml) added to pre-mixed fluids
Trial: 26906014
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg before surgery, 40 mg morning of surgery, 40 mg daily after surgery)
Trial: 26906014
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg morning of surgery, 40 mg morning after)
Trial: 26502545
Drug: Red-hot needle
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Red-hot needle therapy, treated with cauterized needles on specific acupuncture points, once every other day for 30 days.
Trial: 26502545
Drug: Routine acupuncture,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine acupuncture, treated with filiform needles on specific acupuncture points, once daily for 30 days.
Trial: 23885607
Drug: Motilium (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motilium (10 mg orally, three times a day for 2 weeks)
Trial: 18455211
Drug: PPAR agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPAR agonists
Trial: 707973
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose combination type oral contraceptive
Trial: 31537812
Drug: Chemotherapy (n=82)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (n=82)
Trial: 31537812
Drug: No chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No chemotherapy (n=76)
Trial: 23497336
Drug: Eltrombopag 100
RxNorm normalized name: eltrombopag 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 100 mg daily
Trial: 23648244
Drug: Domestic live
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestic live attenuated hepatitis A vaccine (Group A)
Trial: 23648244
Drug: Domestic inactivated
RxNorm normalized name: domestic cow dander extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domestic inactivated hepatitis A vaccine (Group B)
Trial: 23648244
Drug: Imported inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported inactivated hepatitis A vaccine (Group C)
Trial: 23648244
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (Group D)
Trial: 21645836
Drug: Tinzaparin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin (100 IU/kg subcutaneously daily for 90 days) along with usual postoperative care
Trial: 21645836
Drug: Usual postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual postoperative care including chemotherapy when indicated
Trial: 17089021
Drug: SPS (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SPS (600 mg daily)
Trial: 9207819
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg once daily
Trial: 7820217
Drug: Insulin bolus
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin bolus 0.15-0.75 U/kg
Trial: 7820217
Drug: Insulin withdrawal
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin withdrawal and 3 days of intensive insulin therapy
Trial: 3124602
Drug: Stepwise increase
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepwise increase in daily dosage (1 to 4 g/kg) at a steady rate over 24 hours
Trial: 3124602
Drug: Stepwise increase
RxNorm normalized name: Incruse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stepwise increase in daily dosage (1 to 4 g/kg) at a steady rate over 16 hours, followed by a rest period of eight hours
Trial: 3124602
Drug: Full dosage
RxNorm normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full dosage (4 g/kg) at a steady rate over 24 hours
Trial: 30956160
Drug: Single-implant overdentures
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-implant overdentures (IODs)
Trial: 27739230
Drug: ARC-520 Injection
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ARC-520 Injection (0.01-4.0 mg/kg)
Trial: 26220024
Drug: Non-drug-using healthy
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-drug-using healthy males
Trial: 22903391
Drug: Lurasidone 40
RxNorm normalized name: lurasidone 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 40 mg
Trial: 22903391
Drug: Lurasidone 120
RxNorm normalized name: lurasidone 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lurasidone 120 mg
Trial: 21764706
Drug: Octreotide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (100 µg daily subcutaneous injection for 7 days)
Trial: 18385744
Drug: Eprosartan (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprosartan (600 mg day(‐1))
Trial: 18385744
Drug: Hypertensive patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertensive patients (without treatment)
Trial: 11073734
Drug: 4% tea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% tea tree oil nasal ointment and 5% tea tree oil body wash
Trial: 11073734
Drug: 2% mupirocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% mupirocin nasal ointment and triclosan body wash
Trial: 8762212
Drug: Combined slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined slow-release verapamil (180 mg daily) and trandolapril (1.6 mg daily)
Trial: 8762212
Drug: Atenolol (71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (71 mg daily) and chlortalidone (18 mg daily)
Trial: 1315294
Drug: Six additional
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Six additional cycles of chemotherapy (lomustine, cyclophosphamide, doxorubicin, etoposide)
Trial: 1315294
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional treatment until relapse (control group)
Trial: 27452639
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplement of n-3 PUFA (720mg 20:5n3 + 480mg 22:6n3/d)
Trial: 15871441
Drug: Albuterol 180
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol 180 microg QID via pMDI
Trial: 8334946
Drug: Cyclophosphamide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (500 mg/m2 initially, increased by 250 mg/m2 to a maximum of 1,000 mg/m2, administered in cycles every 4 weeks)
Trial: 8334946
Drug: Cyclophosphamide (overall
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclophosphamide (overall treatment)
Trial: 31818839
Drug: Self-regulation intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-regulation intervention including daily weighing, tracking weight using an app, planning daily actions for weight loss, and weekly reflection on action plans.
Trial: 31818839
Drug: Daily self-weighing
RxNorm normalized name: DAILY SELF DISCOVERY SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily self-weighing without further support (control group).
Trial: 31818839
Drug: Daily self-weighing
RxNorm normalized name: DAILY SELF DISCOVERY SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily self-weighing (control group).
Trial: 23892493
Drug: Cumulative Comfort
RxNorm normalized name: Comfort Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative Comfort (CC) for DT1
Trial: 23892493
Drug: Cumulative Comfort
RxNorm normalized name: Comfort Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative Comfort (CC) for asymptomatic group
Trial: 15243483
Drug: Wand Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wand Plus injection system
Trial: 11692587
Drug: Sotalol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol (80 mg orally daily starting on postoperative day 1 for 14 days)
Trial: 9130032
Drug: Methylprednisolone (METH,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (METH, 125 mg i.v. infusion followed by 40 mg/d orally for 4 days)
Trial: 9130032
Drug: Methylprednisolone (METH,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (METH, 40 mg/d orally for 4 days)
Trial: 3310197
Drug: Omeprazole (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (80 mg) administered by intravenous injection
Trial: 3310197
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered by intravenous injection
Trial: 20810853
Drug: Single‐fraction radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single‐fraction radiation therapy of 700 cGy immediately postoperatively (within seventy‐two hours)
Trial: 20810853
Drug: Single‐fraction radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single‐fraction radiation therapy
Trial: 9072308
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg dolasetron
Trial: 9072308
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg dolasetron
Trial: 8257492
Drug: 0.01 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg rhRlx intravenous (iv)
Trial: 8257492
Drug: 0.75 mg
RxNorm normalized name: propinox 0.75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 mg rhRlx intracervical
Trial: 8257492
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg rhRlx intravaginal
Trial: 8257492
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg rhRlx (placebo) intravaginal
Trial: 8257492
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg rhRlx intravaginal
Trial: 8257492
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg rhRlx intravaginal
Trial: 29313746
Drug: Resveratrol (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol (600 mg daily)
Trial: 24122760
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (chemotherapy without bevacizumab)
Trial: 22514150
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atorvastatin 80 mg/day × 2 days before and 40 mg/day × 30 days after PCI
Trial: 22514150
Drug: Intensive atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive atorvastatin treatment
Trial: 18403272
Drug: High-dose cannabis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cannabis (7%)
Trial: 18403272
Drug: Low-dose cannabis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose cannabis (3.5%)
Trial: 14620385
Drug: Wood creosote
RxNorm normalized name: Wood creosote
DrugBank: Wood creosote (DB13271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wood creosote (45, 90, 135, 180, and 225 mg)